Methods Of Inhibiting Fibrogenesis And Treating Fibrotic Disease


Ontology type: sgo:Patent     


Patent Info

DATE

2011-04-07T00:00

AUTHORS

MANN, JELENA , CHU, CHUNG, K. , MANN, DEREK, A.

ABSTRACT

The present invention relates to the discovery of an epigenetic relay pathway that controls hepatic stellate cell activation and the wound-healing response in fibrogenesis, including fibrogenesis of the injured liver. Methods of inhibiting fibrogenesis, including liver fibrogenesis and secondary disease states and conditions thereof, and in treating liver damage, including cirrhosis of the liver (which may be caused by viruses or chemicals, including alcohol), are aspects of the present invention. The methods utilize certain nucleoside compounds and/or antibodies which are optionally conjugated. Pharmaceutical compositions represent additional aspects of the invention. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3197", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "MANN, JELENA", 
        "type": "Person"
      }, 
      {
        "name": "CHU, CHUNG, K.", 
        "type": "Person"
      }, 
      {
        "name": "MANN, DEREK, A.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ncpgasthep0055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011253775", 
          "https://doi.org/10.1038/ncpgasthep0055"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncpgasthep0055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011253775", 
          "https://doi.org/10.1038/ncpgasthep0055"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4401979", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031115443", 
          "https://doi.org/10.1038/sj.cdd.4401979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4401979", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031115443", 
          "https://doi.org/10.1038/sj.cdd.4401979"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-04-07T00:00", 
    "description": "

The present invention relates to the discovery of an epigenetic relay pathway that controls hepatic stellate cell activation and the wound-healing response in fibrogenesis, including fibrogenesis of the injured liver. Methods of inhibiting fibrogenesis, including liver fibrogenesis and secondary disease states and conditions thereof, and in treating liver damage, including cirrhosis of the liver (which may be caused by viruses or chemicals, including alcohol), are aspects of the present invention. The methods utilize certain nucleoside compounds and/or antibodies which are optionally conjugated. Pharmaceutical compositions represent additional aspects of the invention.

", "id": "sg:patent.WO-2010090723-A3", "keywords": [ "fibrotic disease", "invention", "discovery", "pathway", "hepatic stellate cell activation", "wound healing response", "fibrogenesis", "injured liver", "method", "liver fibrogenesis", "secondary disease", "condition", "liver damage", "fibrosis", "liver", "virus", "chemical", "alcohol", "aspect", "nucleoside", "antibody", "pharmaceutical", "additional aspect" ], "name": "METHODS OF INHIBITING FIBROGENESIS AND TREATING FIBROTIC DISEASE", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.1006.7", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.213876.9", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2010090723-A3" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:07", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00184.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2010090723-A3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2010090723-A3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2010090723-A3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2010090723-A3'


 

This table displays all metadata directly associated to this object as RDF triples.

63 TRIPLES      15 PREDICATES      40 URIs      31 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2010090723-A3 schema:about anzsrc-for:3197
2 schema:author N4af29bed3939498eb734e1d5add0a827
3 schema:citation sg:pub.10.1038/ncpgasthep0055
4 sg:pub.10.1038/sj.cdd.4401979
5 schema:datePublished 2011-04-07T00:00
6 schema:description <p>The present invention relates to the discovery of an epigenetic relay pathway that controls hepatic stellate cell activation and the wound-healing response in fibrogenesis, including fibrogenesis of the injured liver. Methods of inhibiting fibrogenesis, including liver fibrogenesis and secondary disease states and conditions thereof, and in treating liver damage, including cirrhosis of the liver (which may be caused by viruses or chemicals, including alcohol), are aspects of the present invention. The methods utilize certain nucleoside compounds and/or antibodies which are optionally conjugated. Pharmaceutical compositions represent additional aspects of the invention.</p>
7 schema:keywords additional aspect
8 alcohol
9 antibody
10 aspect
11 chemical
12 condition
13 discovery
14 fibrogenesis
15 fibrosis
16 fibrotic disease
17 hepatic stellate cell activation
18 injured liver
19 invention
20 liver
21 liver damage
22 liver fibrogenesis
23 method
24 nucleoside
25 pathway
26 pharmaceutical
27 secondary disease
28 virus
29 wound healing response
30 schema:name METHODS OF INHIBITING FIBROGENESIS AND TREATING FIBROTIC DISEASE
31 schema:recipient https://www.grid.ac/institutes/grid.1006.7
32 https://www.grid.ac/institutes/grid.213876.9
33 schema:sameAs https://app.dimensions.ai/details/patent/WO-2010090723-A3
34 schema:sdDatePublished 2019-04-18T10:07
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher Nd1d879ff291c40cbbed81fcb2aa3fb2e
37 sgo:license sg:explorer/license/
38 sgo:sdDataset patents
39 rdf:type sgo:Patent
40 N23d3f93254564d64bbbe7c5924ca7f52 schema:name MANN, JELENA
41 rdf:type schema:Person
42 N4034fa451943474f8acc90a434b11061 rdf:first N5932cd9fb1ce4de69b0611936a0f08c3
43 rdf:rest rdf:nil
44 N4af29bed3939498eb734e1d5add0a827 rdf:first N23d3f93254564d64bbbe7c5924ca7f52
45 rdf:rest N77a53f74eb5c491e8d91d55f105581a8
46 N5932cd9fb1ce4de69b0611936a0f08c3 schema:name MANN, DEREK, A.
47 rdf:type schema:Person
48 N7058f93d179a4075b8b97ec04e60a946 schema:name CHU, CHUNG, K.
49 rdf:type schema:Person
50 N77a53f74eb5c491e8d91d55f105581a8 rdf:first N7058f93d179a4075b8b97ec04e60a946
51 rdf:rest N4034fa451943474f8acc90a434b11061
52 Nd1d879ff291c40cbbed81fcb2aa3fb2e schema:name Springer Nature - SN SciGraph project
53 rdf:type schema:Organization
54 anzsrc-for:3197 schema:inDefinedTermSet anzsrc-for:
55 rdf:type schema:DefinedTerm
56 sg:pub.10.1038/ncpgasthep0055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011253775
57 https://doi.org/10.1038/ncpgasthep0055
58 rdf:type schema:CreativeWork
59 sg:pub.10.1038/sj.cdd.4401979 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031115443
60 https://doi.org/10.1038/sj.cdd.4401979
61 rdf:type schema:CreativeWork
62 https://www.grid.ac/institutes/grid.1006.7 schema:Organization
63 https://www.grid.ac/institutes/grid.213876.9 schema:Organization
 




Preview window. Press ESC to close (or click here)


...